Patient-Reported Outcomes and Quality of Life Improved with Fluticasone Propionate and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhalers Versus Placebo in Patients with Persistent Asthma

被引：1

作者：

Raphael, Gordon ^{[1
]}

Yiu, Gloria ^{[2
]}

Sakov, Anat ^{[3
]}

Liu, Siyu ^{[2
]}

Caracta, Cynthia ^{[2
]}

机构：

[1] Bethesda Allergy Asthma & Res Ctr, Bethesda, MD USA

[2] Teva Pharmaceut, Frazer, PA USA

[3] Teva Pharmaceut, Netanya, Israel

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2016.12.086

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：AB10 / AB10

页数：1

共 50 条

[1] Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma
Sher, Lawrence D.
Yiu, Gloria
Sakov, Anat
Liu, Siyu
Caracta, Cynthia F.
ALLERGY AND ASTHMA PROCEEDINGS, 2017, 38 (05) : 343 - 353
[2] Treatment of Asthmatic Patients with Fluticasone Propionate and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhalers Compared with Placebo: Patient-Reported Outcomes and Quality of Life
Sher, Lawrence
Yiu, Gloria
Sakov, Anat
Liu, Siyu
Caracta, Cynthia
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB97 - AB97
[3] FLUTICASONE PROPIONATE AND FLUTICASONE/SALMETEROL MULTIDOSE DRY POWDER INHALERS COMPARED WITH PLACEBO FOR PERSISTENT ASTHMA
Sher, L.
Yiu, G.
Sakov, A.
Liu, S.
Caracta, C.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S61 - S62
[4] FLUTICASONE PROPIONATE AND FLUTICASONE PROPIONATE/SALMETEROL DELIVERED VIA MULTIDOSE DRY POWDER INHALERS FOR PERSISTENT ASTHMA
Raphael, G.
Yiu, G.
Sakov, A.
Liu, S.
Caracta, C.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S63 - S63
[5] FLUTICASONE PROPIONATE AND FLUTICASONE PROPIONATE/SALMETEROL MULTIDOSE DRY POWDER INHALER PHARMACOKINETICS IN PATIENTS WITH PERSISTENT ASTHMA
Ratner, P.
Yiu, G.
Nugent, C.
Song, S.
Caracta, C.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S65 - S66
[6] A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma
Mansfield, Lyndon
Yiu, Gloria
Sakov, Anat
Liu, Siyu
Caracta, Cynthia
ALLERGY AND ASTHMA PROCEEDINGS, 2017, 38 (04) : 264 - 276
[7] LONG-TERM SAFETY OF FLUTICASONE PROPIONATE AND FLUTICASONE PROPIONATE/SALMETEROL MULTIDOSE DRY POWDER INHALERS IN ASTHMATIC PATIENTS
Mansfield, L.
Yiu, G.
Sakov, A.
Liu, S.
Caracta, C.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S65 - S65
[8] FLUTICASONE PROPIONATE AND FLUTICASONE/SALMETEROL MULTIDOSE DRY POWDER INHALERS IN PATIENTS PREVIOUSLY TREATED THROUGH ALTERNATIVE DEVICES
Bernstein, D.
Small, C.
Yiu, G.
Stoyanov, S.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S52 - S52
[9] The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma
Condemi, JJ
Goldstein, S
Kalberg, C
Yancey, S
Emmett, A
Rickard, K
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 383 - 389
[10] Randomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder inhalers in patients with persistent asthma aged 12 years and older
Raphael, Gordon
Yiu, Gloria
Sakov, Anat
Liu, Siyu
Caracta, Cynthia
JOURNAL OF ASTHMA, 2018, 55 (06) : 640 - 650

← 1 2 3 4 5 →